INS and COVID-19: It is well established that insulin resistance, particularly diminished insulin responses in peripheral tissues such as skeletal muscle, adipose tissue, and liver, in combination with or without β cell dysfunction, ultimately leads to hyperglycemia and a series of complications.51 Recently, several studies have investigated the mechanisms of COVID-19-related insulin resistance.